Health insurance solved sustained engagement with prevention before P&C did. The lesson is transferable. The data appetite is not. The route that resolves the tension runs through employee benefits — and through signal the insurer never has to hold.
A property and casualty insurer offers a discount for installing a leak sensor, a telematics box, or a connected safety device. The customer accepts, the device goes in, and the relationship effectively ends. The discount is priced once, at inception, and never revisited. Contrast this with how health and life insurers have spent the last decade building propositions around wearables: not a one-time reward for owning a device, but a continuous loop that keeps the customer engaged with their own risk, month after month.
That difference is not cosmetic. It is the single most transferable idea P&C can take from health insurance — and, handled carelessly, the one most likely to import a data problem P&C is neither structured nor capitalised to hold. This piece sets out what is worth borrowing, where the two markets must diverge, and why the pathway that reconciles the two runs through employee benefits rather than through the individual policyholder. The evidence here is drawn from the UK market — its group-risk data, its privacy regime — but the structure travels: the same tension, and the same resolution, recur wherever sensitive health data meets commercial insurance.
What is actually worth borrowing: the incentive architecture
The instinct is to say the lesson is “wearables.” It is not. Wearables are commodity hardware. What health insurance built around them — the shared-value engagement loop pioneered by Vitality and now widely imitated — is the part that is hard to replicate and worth studying: rewards, status tiers, subsidised devices, and a feedback rhythm that sustains behaviour change over years rather than weeks.
This matters because it solves the problem that defeats most P&C risk-control programmes. As we have argued elsewhere, most of what the industry calls “loss control” is really loss observation — the technology watches, but nothing changes behaviour. The behavioural-science reason is well understood: capability, opportunity and motivation must all be present for a behaviour to occur, and a one-time discount supplies none of them past the moment of installation. Health insurance got to sustained motivation first, partly because morbidity rewards prevention over long horizons and partly because the economics forced the issue.
And the model is not theoretical. In the UK group-risk market — employer-sponsored life, income protection and critical illness — the “insurer as health partner” model already operates at scale.
The UK group-risk sector paid a record £2.69bn in claims in 2025, covering more than 15.7 million insured people. But the more instructive figure is upstream of claims: of the employees helped back to work during the year, 3,920 returned before a claim was ever made, following early intervention from their insurer, and insurers delivered roughly 8,300 health and wellbeing interventions — most within six months of first absence.
Sources: GRiD 2026 Claims Survey; Swiss Re Group Watch 2025.
Read that as a P&C proposition and the point is sharp: engagement and early intervention suppress claims before they crystallise. That is precisely the mechanism P&C keeps failing to build. Group risk has already built it.
Where the two markets must diverge
Borrowing the incentive architecture does not license borrowing the data appetite. Three divergences are non-negotiable.
Data category. Health and biometric data is special-category data under Article 9 of the UK GDPR. That is a higher bar in kind, not merely in degree, than the location and behavioural data behind telematics or property sensors. It carries explicit-consent requirements, tighter lawful-basis constraints, and a heavier accountability burden. A P&C insurer treating heart-rate or sleep data with the same instincts it applies to a telematics feed is not a little exposed — it is operating under a different legal regime and may not know it. The same exceptional status attaches almost everywhere — under HIPAA and the Americans with Disabilities Act in the US, the EU GDPR across Europe — so the point is not parochial to one jurisdiction: sensitive health data is treated as a category apart wherever it is held.
Custody as strategic liability. This is the strategic point, and it is easy to miss. For a P&C carrier or a risk-technology vendor, holding raw sensitive health data is not an asset — it is a liability. It expands the breach surface, invites regulatory scrutiny, and creates reputational exposure that may sit well outside the organisation’s risk appetite and capital position. The correct architectural conclusion is therefore not “collect more health data.” It is: acquire the signal — activity, behavioural risk, fatigue — without taking custody of the raw biometrics. Derived indicators over raw feeds; edge or federated processing over central ingestion; a health-native custodian in the middle rather than the P&C balance sheet.
Fairness scaffolding. Health insurance has decades of anti-discrimination architecture built around a principle P&C does not yet apply reflexively to health-adjacent data: reward what people do, not who they are. A P&C insurer importing health signal naively will trip fairness constraints it was never designed to navigate — pricing on demographic proxies dressed up as behavioural ones.
The link is real: activity, fatigue and the claim
The case for touching health signal at all rests on a genuine causal chain, and the fleet context makes it concrete. Loughborough University’s SHIFT programme — a randomised controlled trial of 382 long-distance HGV drivers across 25 UK transport sites, funded by the NIHR — demonstrated that structured intervention combined with wearable activity trackers measurably improved driver activity levels. The wider occupational-health literature is consistent: low physical activity, prolonged sedentary time and disrupted sleep are associated with elevated fatigue, and fatigue is a well-established precursor to road-traffic accidents.
There is a detail here that does more work than it first appears. In the research, fatigue is rarely measured directly — it is inferred through proxies: sleepiness scales, reaction-time and vigilance measures, driver-performance indicators. In other words, even the clinicians do not want the raw internal state; they want a defensible signal that stands in for it. That is exactly the posture a P&C underwriter should adopt.
An engaged, active workforce is a lower-frequency workforce — not because health data prices the driver, but because fatigue sits on the causal path to the claim. The insurer does not need the biometrics. It needs a fatigue-risk signal it can defend. The health literature already treats fatigue this way; the underwriter should too.
A note on evidence — and the opportunity inside it. The activity–fatigue–accident chain is a well-supported mechanism with strong priors, not a priced, holdout-tested loss result — and that is precisely what makes it actionable. It gives an underwriter the empirical backing to run a structured, book-specific pilot: hold the mechanism fixed, instrument the intervention, and quantify the exact rate reduction against real portfolio experience. The number is not asserted here because it is not ours to assert — it is the output of the evidence build, measured on your own book.
And it does not stay in the cab. Long-haul fleet gives the cleanest, best-studied data on fatigue-driven loss, which is why it anchors the argument here — but the same activity-and-fatigue mechanisms drive injury frequency across manufacturing, warehousing, logistics and general commercial casualty. The fleet is the clearest illustration of a pattern that runs through the whole employer book — which is exactly where the pathway leads next.
Employee benefits: the pathway that resolves the tension
Here is why the benefits channel is the unlock rather than a footnote. At the level of the individual P&C policyholder, the convergence of P&C and health signal is blocked on three fronts at once: consent (explicit, special-category, revocable), adverse selection (who volunteers their health data, and why), and the custody liability set out above. Each is serious. Together they are usually fatal to a direct-to-consumer play.
The group, employer-sponsored structure dissolves most of that in a single move. Participation becomes opt-in workplace wellbeing rather than a condition of individual cover. Data aggregates to population level rather than resolving to a named individual. The employer sponsors the arrangement and carries the primary relationship with the workforce. And the insurer accesses risk signal without taking individual custody of anyone’s biometrics.
The connective tissue that makes this legitimate for a P&C insurer — rather than an opportunistic land-grab — is casualty. Employers’ liability, workers’ compensation and injury prevention are the classes where employee health is the insured risk. This is the one place a P&C carrier has a defensible, underwriting-relevant reason to want health-adjacent signal at all. The fleet analogy is exact: a telematics fleet insurer already monitors driver behaviour, and driver fatigue and wellbeing are simultaneously an occupational-health question and a claims-frequency question. The same data has two owners’ worth of relevance.
So the pathway runs in a specific order, and the order matters:
Existing commercial P&C relationship (fleet, property, liability) → occupational health and injury prevention (the casualty overlap) → workplace wellbeing and employee benefits.
The insurer already embedded with the employer on its commercial lines has the relationship that is the natural bridge into benefits — and enters via the class (casualty) where health signal is legitimately underwriting-relevant, using the group structure to sidestep the individual-consent and custody problems that block the direct route.
The reframe: a custody-and-distribution question, not a product question
Put the pieces together and the strategic question changes shape. “Should P&C get into health data?” is the wrong question — it invites either a reckless yes or a defensive no. The right question is architectural.
The winner is not whoever ingests the most health data. It is whoever structures access to health signal through the employer channel without taking custody of the raw data — and converts that signal into both loss control on casualty lines and a benefits proposition. Signal in, custody out, distribution through the employer.
The implication for technology vendors
For the behavioural-health, wearables and fatigue-detection vendors we assess, this reframes the route to market. The instinct is to pitch a carrier’s underwriting team directly. But if the legitimate entry point for health signal into P&C is the casualty-and-benefits channel, then the fastest route may not be direct-to-carrier at all — it may run through the employer, the group scheme, or the broker who already places that employer’s commercial programme. A vendor whose data reduces occupational injury frequency has a stronger, cleaner story told through employee benefits and casualty than told as another underwriting-input pitch to a motor or property desk.
One discipline note, because it determines whether any of this holds together: the value is in the shape of the signal a workforce produces, not merely its level — the difference between a managed workforce and a merely monitored one lives in the distribution, not the average. That is a technical argument in its own right, and we develop it separately in our companion piece on what underwriters should extract from risk-technology data. For the purposes of this piece, it is enough to note that the benefits bridge delivers a P&C insurer to the doorstep of health signal — and that the value of crossing it depends entirely on refusing to carry the raw data across with you.
Whether you are a commercial carrier looking to reach lower-frequency casualty books or a health-technology vendor seeking a defensible route to market, the mandate is the same: design for the employer ecosystem, respect the boundaries around sensitive data, and build for actionable signal rather than data hoarding. The prize is a book that behaves better because the risk is being managed, not merely observed — and a relationship structured so that no one at the table is holding data they should not.
Building a proposition at the edge of health and casualty?
The Partnership Readiness Diagnostic helps you structure the evidence, the data architecture, and the route to market before the conversation that matters.
Take the free diagnostic →